Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical Prostatectomy-Reference-Cited by-同舟云学术

Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical Prostatectomy

Published:2003-09 Issue:3 Volume:170 Page:791-794
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KLOTZ L.H.¹,GOLDENBERG S.L.¹,JEWETT M.A.S.¹,FRADET Y.¹,NAM R.¹,BARKIN J.¹,CHIN J.¹,CHATTERJEE S.¹,

Affiliation:

1. From the Division of Urology, Sunnybrook and Women’s College Health Sciences Centre (LHK, RN, SC) and Princess Margaret Hospital (MASJ), University of Toronto, Humber River Regional Hospital (JB), Toronto, University of Western Ontario (JC), London, Ontario, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia (SLG), and Universite de Laval, Quebec, Canada (YF)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer;Goldenberg;J Urol,1996

2. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results;Soloway;J Urol,2002

3. Hormonal treatment before radical prostatectomy: a 3-year followup;Aus;J Urol,1998

4. CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group;Klotz;Urology,1999

5. Neoadjuvant hormonal treatment prior to radical prostatectomy: follow-up of a prospective randomized study;Wildschutz;Eur Urol,1996

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07

2. Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2024-06

3. Androgen deprivation therapy in localized prostate cancer. Current status and future trends;Actas Urológicas Españolas (English Edition);2022-08

4. Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence;Cancer Discovery;2022-06-27

5. Terapia de privación de andrógenos en el cáncer de próstata localizado. Situación actual y tendencias futuras;Actas Urológicas Españolas;2022-06